Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

Literature DB >> 24638016

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

Lee M Ellis¹, David S Bernstein, Emile E Voest, Jordan D Berlin, Daniel Sargent, Patricia Cortazar, Elizabeth Garrett-Mayer, Roy S Herbst, Rogerio C Lilenbaum, Camelia Sima, Alan P Venook, Mithat Gonen, Richard L Schilsky, Neal J Meropol, Lowell E Schnipper.

Abstract

Mesh：

Year: 2014 PMID： 24638016 DOI： 10.1200/JCO.2013.53.8009

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

124 in total

Review 1. Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer.

Authors: Sara Pilotto; Luisa Carbognin; Niki Karachaliou; Marina Garassino; Federica Cuppone; Sandra Petraglia; Rafael Rosell; Giampaolo Tortora; Emilio Bria
Journal: Transl Lung Cancer Res Date: 2015-12

Review 2. Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.

Authors: Giovanni Barosi
Journal: Curr Hematol Malig Rep Date: 2015-12 Impact factor: 3.952

Review 3. Current challenges in health economic modeling of cancer therapies: a research inquiry.

Authors: Jeffrey D Miller; Kathleen A Foley; Mason W Russell
Journal: Am Health Drug Benefits Date: 2014-05

4. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Authors: Lowell E Schnipper; Nancy E Davidson; Dana S Wollins; Courtney Tyne; Douglas W Blayney; Diane Blum; Adam P Dicker; Patricia A Ganz; J Russell Hoverman; Robert Langdon; Gary H Lyman; Neal J Meropol; Therese Mulvey; Lee Newcomer; Jeffrey Peppercorn; Blase Polite; Derek Raghavan; Gregory Rossi; Leonard Saltz; Deborah Schrag; Thomas J Smith; Peter P Yu; Clifford A Hudis; Richard L Schilsky
Journal: J Clin Oncol Date: 2015-06-22 Impact factor: 44.544

5. The lesson learned from figitumumab clinical program and the hope for better results in squamous lung cancer.

Authors: Massimo Di Maio; Giorgio Vittorio Scagliotti
Journal: Transl Lung Cancer Res Date: 2015-02

6. Another disappointing result, but how good is it?

Authors: Yasushi Goto
Journal: J Thorac Dis Date: 2017-06 Impact factor: 2.895

7. Is the door open to further investigation with antiangiogenesis in SCLC?

Authors: Marcello Tiseo; Luca Boni; Andrea Ardizzoni
Journal: J Thorac Dis Date: 2018-04 Impact factor: 2.895

8. Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Authors: Joshua M Bauml; Ravi Vinnakota; Yeun-Hee Anna Park; Susan E Bates; Tito Fojo; Charu Aggarwal; Sewanti Limaye; Nevena Damjanov; Jessica Di Stefano; Christine Ciunci; Eric M Genden; Juan P Wisnivesky; Rocco Ferrandino; Ronac Mamtani; Corey J Langer; Roger B Cohen; Keith Sigel
Journal: J Natl Cancer Inst Date: 2019-05-01 Impact factor: 13.506

9. Overall survival in non-small cell lung cancer-what is clinically meaningful?

Authors: Klaus Fenchel; Ludger Sellmann; Wolfram C M Dempke
Journal: Transl Lung Cancer Res Date: 2016-02

Review 10. Chemotherapy for advanced gastric cancer.

Authors: Anna Dorothea Wagner; Nicholas Lx Syn; Markus Moehler; Wilfried Grothe; Wei Peng Yong; Bee-Choo Tai; Jingshan Ho; Susanne Unverzagt
Journal: Cochrane Database Syst Rev Date: 2017-08-29